1. Home
  2. LYG vs BSX Comparison

LYG vs BSX Comparison

Compare LYG & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lloyds Banking Group Plc

LYG

Lloyds Banking Group Plc

N/A

Current Price

$5.25

Market Cap

82.5B

Sector

Finance

ML Signal

N/A

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

N/A

Current Price

$71.93

Market Cap

137.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LYG
BSX
Founded
1695
1979
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Commercial Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.5B
137.8B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
LYG
BSX
Price
$5.25
$71.93
Analyst Decision
Hold
Strong Buy
Analyst Count
1
20
Target Price
N/A
$109.15
AVG Volume (30 Days)
25.7M
12.8M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
3.37%
N/A
EPS Growth
N/A
55.20
EPS
N/A
1.94
Revenue
N/A
$9,076,000,000.00
Revenue This Year
$13.39
$12.04
Revenue Next Year
$7.12
$10.48
P/E Ratio
$62.13
$36.74
Revenue Growth
N/A
12.49
52 Week Low
$3.27
$70.75
52 Week High
$6.34
$109.50

Technical Indicators

Market Signals
Indicator
LYG
BSX
Relative Strength Index (RSI) 36.22 33.48
Support Level $4.39 N/A
Resistance Level $5.54 $76.77
Average True Range (ATR) 0.13 1.76
MACD -0.07 0.31
Stochastic Oscillator 21.11 25.43

Price Performance

Historical Comparison
LYG
BSX

About LYG Lloyds Banking Group Plc

Lloyds is a retail and commercial bank headquartered in the United Kingdom. The bank operates via three business segments: retail, commercial banking, and insurance and wealth. In retail, Lloyds offers primarily mortgages (66% of loan portfolio), credit cards, and current accounts to its customers. Its commercial banking operation provides lending, transaction banking, working capital management, and debt capital market services to large companies and financial institutions in the UK. Insurance and wealth round out the product lineup with life and property insurance as well as pension solutions and high-net-worth asset management services.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: